Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Impact of symptoms and risk of ASMD on patients and caregivers

Impact of symptoms and risk of ASMD on patients and caregivers

Consensus Guidelines for the Clinical Management of ASMD

Consensus Guidelines for the Clinical Management of ASMD

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Inside Diabetes: ATTD Edition | Type 1 Diabetes

Inside Diabetes: ATTD Edition | Type 1 Diabetes

Diagnosing Fabry Disease in Clinical Practice

Diagnosing Fabry Disease in Clinical Practice

Biochemical Diagnostic Strategy in Females Suspected of Fabry Disease

Biochemical Diagnostic Strategy in Females Suspected of Fabry Disease

Role of Ecg in Differential Diagnosis of Anderson - Fabry Disease with HCM

Role of Ecg in Differential Diagnosis of Anderson - Fabry Disease with HCM

Management of ASMD - Expert opinion: Professor Fatma Al- Jasmi

Management of ASMD - Expert opinion: Professor Fatma Al- Jasmi

Professor Fatma explains the effect of Olipudase Alfa on the symptoms presented in patients with ASMD.

Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

Molecular Pathway

Molecular Pathway

Other Treatment Options

Other Treatment Options

Impact on Patients

Impact on Patients